These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 34097185)
21. Soluble TREM2, Alzheimer's Disease Pathology, and Risk for Progression of Cerebral Small Vessel Disease: A Longitudinal Study. Wu C; Ma YH; Hu H; Zhao B; Tan L; J Alzheimers Dis; 2023; 92(1):311-322. PubMed ID: 36744335 [TBL] [Abstract][Full Text] [Related]
22. CSF glial biomarkers YKL40 and sTREM2 are associated with longitudinal volume and diffusivity changes in cognitively unimpaired individuals. Falcon C; Monté-Rubio GC; Grau-Rivera O; Suárez-Calvet M; Sánchez-Valle R; Rami L; Bosch B; Haass C; Gispert JD; Molinuevo JL Neuroimage Clin; 2019; 23():101801. PubMed ID: 30978656 [TBL] [Abstract][Full Text] [Related]
23. sTREM2 mediates the associations of minimal depressive symptoms with amyloid pathology in prodromal Alzheimer's disease: The CABLE study. Wang ZB; Sun Y; Ma YH; Fu Y; Hu H; Xu W; Wang ZT; Ma LZ; Tan L; Yu JT Transl Psychiatry; 2022 Apr; 12(1):140. PubMed ID: 35379792 [TBL] [Abstract][Full Text] [Related]
24. Cerebrospinal Fluid sTREM2 Has Paradoxical Association with Brain Structural Damage Rate in Early- and Late-Stage Alzheimer's Disease. Leng F; Zhan Z; Sun Y; Liu F; Edison P; Sun Y; Wang Z; J Alzheimers Dis; 2022; 88(1):117-126. PubMed ID: 35491791 [TBL] [Abstract][Full Text] [Related]
25. The longitudinal trajectory of CSF sTREM2: the alzheimer's disease neuroimaging initiative. Wang Y; Ye M; Ji Q; Liu Q; Xu X; Zhan Y Alzheimers Res Ther; 2024 Jun; 16(1):138. PubMed ID: 38926894 [TBL] [Abstract][Full Text] [Related]
27. Sleep characteristics and cerebrospinal fluid biomarkers of Alzheimer's disease pathology in cognitively intact older adults: The CABLE study. Xu W; Tan L; Su BJ; Yu H; Bi YL; Yue XF; Dong Q; Yu JT Alzheimers Dement; 2020 Aug; 16(8):1146-1152. PubMed ID: 32657026 [TBL] [Abstract][Full Text] [Related]
28. sTREM2 Mediates the Correlation Between BIN1 Gene Polymorphism and Tau Pathology in Alzheimer's Disease. Guo F; Tan MS; Hu H; Ou YN; Zhang MZ; Sheng ZH; Chi HC; Tan L; J Alzheimers Dis; 2024; 101(2):693-704. PubMed ID: 39240638 [TBL] [Abstract][Full Text] [Related]
29. Association between Cerebrospinal Fluid sTREM2 Levels and Depression: The Alzheimer's Disease Neuroimaging Initiative Study. Wang Y; Ye M; Ji Q; Liu Q; Xu X; Zhan Y J Prev Alzheimers Dis; 2024; 11(4):1087-1092. PubMed ID: 39044521 [TBL] [Abstract][Full Text] [Related]
30. Association between air pollution and CSF sTREM2 in cognitively normal older adults: The CABLE study. Li M; Ma YH; Fu Y; Liu JY; Hu HY; Zhao YL; Huang LY; Tan L Ann Clin Transl Neurol; 2022 Nov; 9(11):1752-1763. PubMed ID: 36317226 [TBL] [Abstract][Full Text] [Related]
32. TREM2 ectodomain and its soluble form in Alzheimer's disease. Yang J; Fu Z; Zhang X; Xiong M; Meng L; Zhang Z J Neuroinflammation; 2020 Jul; 17(1):204. PubMed ID: 32635934 [TBL] [Abstract][Full Text] [Related]
33. CSF concentrations of soluble TREM2 as a marker of microglial activation in HIV-1 infection. Gisslén M; Heslegrave A; Veleva E; Yilmaz A; Andersson LM; Hagberg L; Spudich S; Fuchs D; Price RW; Zetterberg H Neurol Neuroimmunol Neuroinflamm; 2019 Jan; 6(1):e512. PubMed ID: 30568991 [TBL] [Abstract][Full Text] [Related]
34. Genome-wide association study identifies Alzheimer's risk variant in MS4A6A influencing cerebrospinal fluid sTREM2 levels. Hou XH; Bi YL; Tan MS; Xu W; Li JQ; Shen XN; Dou KX; Tan CC; Tan L; ; Yu JT Neurobiol Aging; 2019 Dec; 84():241.e13-241.e20. PubMed ID: 31204042 [TBL] [Abstract][Full Text] [Related]
35. Early changes in CSF sTREM2 in dominantly inherited Alzheimer's disease occur after amyloid deposition and neuronal injury. Suárez-Calvet M; Araque Caballero MÁ; Kleinberger G; Bateman RJ; Fagan AM; Morris JC; Levin J; Danek A; Ewers M; Haass C; Sci Transl Med; 2016 Dec; 8(369):369ra178. PubMed ID: 27974666 [TBL] [Abstract][Full Text] [Related]
36. Sleep Characteristics and Cerebrospinal Fluid Progranulin in Older Adults: The CABLE Study. Wang M; Sun FR; Bi YL; Ma YH; Yin JJ; Shen XN; Wang XT; Tan L; Yu JT Neurotox Res; 2021 Jun; 39(3):764-773. PubMed ID: 33443646 [TBL] [Abstract][Full Text] [Related]
37. Soluble TREM2 changes during the clinical course of Alzheimer's disease: A meta-analysis. Liu D; Cao B; Zhao Y; Huang H; McIntyre RS; Rosenblat JD; Zhou H Neurosci Lett; 2018 Nov; 686():10-16. PubMed ID: 30171911 [TBL] [Abstract][Full Text] [Related]
38. Glial activation and inflammation along the Alzheimer's disease continuum. Nordengen K; Kirsebom BE; Henjum K; Selnes P; Gísladóttir B; Wettergreen M; Torsetnes SB; Grøntvedt GR; Waterloo KK; Aarsland D; Nilsson LNG; Fladby T J Neuroinflammation; 2019 Feb; 16(1):46. PubMed ID: 30791945 [TBL] [Abstract][Full Text] [Related]
39. Soluble Triggering Receptor Expressed on Myeloid Cells 2 From Cerebrospinal Fluid in Sleep Disorders Related to Parkinson's Disease. Mo M; Tang Y; Wei L; Qiu J; Peng G; Lin Y; Zhou M; Dai W; Zhang Z; Chen X; Liu H; Ding L; Ye P; Wu Y; Zhu X; Wu Z; Guo W; Xu P Front Aging Neurosci; 2021; 13():753210. PubMed ID: 34658845 [No Abstract] [Full Text] [Related]
40. Soluble TREM2 and biomarkers of central and peripheral inflammation in neurodegenerative disease. Bekris LM; Khrestian M; Dyne E; Shao Y; Pillai JA; Rao SM; Bemiller SM; Lamb B; Fernandez HH; Leverenz JB J Neuroimmunol; 2018 Jun; 319():19-27. PubMed ID: 29685286 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]